{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:21:28Z","timestamp":1790014888232,"version":"4.0.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,11,18]],"date-time":"2012-11-18T00:00:00Z","timestamp":1353196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s00345-012-0984-0","type":"journal-article","created":{"date-parts":[[2012,11,17]],"date-time":"2012-11-17T11:19:12Z","timestamp":1353151152000},"page":"1469-1474","source":"Crossref","is-referenced-by-count":36,"title":["An exploratory, placebo-controlled, dose\u2013response study of the efficacy and safety of onabotulinumtoxinA in spinal cord injury patients with urinary incontinence due to neurogenic detrusor overactivity"],"prefix":"10.1007","volume":"31","author":[{"given":"Apostolos","family":"Apostolidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"Mourad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,18]]},"reference":[{"issue":"3 Pt 1","key":"984_CR1","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"164","author":"B Schurch","year":"2000","unstructured":"Schurch B, Stohrer M, Kramer G, Schmid DM, Gaul G, Hauri D (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164(3 Pt 1):692\u2013697","journal-title":"J Urol"},{"issue":"4","key":"984_CR2","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2011.07.001","volume":"60","author":"A Mangera","year":"2011","unstructured":"Mangera A, Andersson KE, Apostolidis A, Chapple C, Dasgupta P, Giannantoni A, Gravas S, Madersbacher S (2011) Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA). Eur Urol 60(4):784\u2013795","journal-title":"Eur Urol"},{"issue":"4","key":"984_CR3","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","volume":"60","author":"F Cruz","year":"2011","unstructured":"Cruz F, Herschorn S, Aliotta P, Brin M, Thompson C, Lam W, Daniell G, Heesakkers J, Haag-Molkenteller C (2011) Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. Eur Urol 60(4):742\u2013750","journal-title":"Eur Urol"},{"issue":"6","key":"984_CR4","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.juro.2012.01.125","volume":"187","author":"D Ginsberg","year":"2012","unstructured":"Ginsberg D, Gousse A, Keppenne V, Sievert KD, Thompson C, Lam W, Brin M, Jenkins B, Haag-Molkenteller C (2012) Phase 3 efficacy and tolerability study of onabotulinumtoxinA in patients with urinary incontinence resulting from neurogenic detrusor overactivity. J Urol 187(6):2131\u20132139","journal-title":"J Urol"},{"issue":"2","key":"984_CR5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","volume":"53","author":"G Karsenty","year":"2008","unstructured":"Karsenty G, Denys P, Amarenco G, De Seze M, Game X, Haab F, Kerdraon J, Perrouin-Verbe B, Ruffion A, Saussine C, Soler JM, Schurch B, Chartier-Kastler E (2008) Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review. Eur Urol 53(2):275\u2013287","journal-title":"Eur Urol"},{"issue":"4","key":"984_CR6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0090-4295(99)00553-1","volume":"55","author":"KJ Weld","year":"2000","unstructured":"Weld KJ, Dmochowski RR (2000) Association of level of injury and bladder behavior in patients with post-traumatic spinal cord injury. Urology 55(4):490\u2013494","journal-title":"Urology"},{"issue":"4","key":"984_CR7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000251175","volume":"83","author":"M Stoehrer","year":"2009","unstructured":"Stoehrer M, Wolff A, Kramer G, Steiner R, Lmochner-Ernst D, Leuth D, Steude U, Ruebben H (2009) Treatment of neurogenic detrusor overactivity with botulinum toxin A: the first seven years. Urol Int 83(4):379\u2013385","journal-title":"Urol Int"},{"issue":"3","key":"984_CR8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2008.08.048","volume":"55","author":"A Giannantoni","year":"2009","unstructured":"Giannantoni A, Mearini E, Del Zingaro M, Porena M (2009) Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results. Eur Urol 55(3):705\u2013711","journal-title":"Eur Urol"},{"issue":"3","key":"984_CR9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/nau.21003","volume":"30","author":"A Manack","year":"2011","unstructured":"Manack A, Motsko SP, Haag-Molkenteller C, Dmochowski RR, Goehring EL Jr, Nguyen-Khoa BA, Jones JK (2011) Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database. Neurourol Urodyn 30(3):395\u2013401","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"984_CR10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","volume":"174","author":"B Schurch","year":"2005","unstructured":"Schurch B, de Seze M, Denys P, Chartier-Kastler E, Haab F, Everaert K, Plante P, Perrouin-Verbe B, Kumar C, Fraczek S, Brin MF (2005) Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 174(1):196\u2013200","journal-title":"J Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-012-0984-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-012-0984-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-012-0984-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:40:05Z","timestamp":1559036405000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-012-0984-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,18]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["984"],"URL":"https:\/\/doi.org\/10.1007\/s00345-012-0984-0","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,18]]}}}